CASPER PHARMA LLC FDA Approval NDA 010721

NDA 010721

CASPER PHARMA LLC

FDA Drug Application

Application #010721

Documents

Letter2012-10-24
Label2012-10-24
Label2018-04-16
Letter2018-04-16
Label2018-12-13
Letter2018-12-20
Label2019-06-03
Letter2019-07-01
Label2019-07-05

Application Sponsors

NDA 010721CASPER PHARMA LLC

Marketing Status

Prescription001
Prescription004
Prescription005
Prescription006

Application Products

001TABLET;ORAL50MG1ANTIVERTMECLIZINE HYDROCHLORIDE
004TABLET;ORAL25MG1ANTIVERTMECLIZINE HYDROCHLORIDE
005TABLET, CHEWABLE;ORAL25MG1ANTIVERTMECLIZINE HYDROCHLORIDE
006TABLET;ORAL12.5MG1ANTIVERTMECLIZINE HYDROCHLORIDE

FDA Submissions

UNKNOWN; ORIG1AP1957-02-14STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL50AP1993-03-12STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL51AP1993-09-17STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL52AP1993-09-02STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL53AP1999-11-10STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL54AP1999-12-14STANDARD
LABELING; LabelingSUPPL58AP2012-10-23STANDARD
EFFICACY; EfficacySUPPL61AP2018-04-13STANDARD
LABELING; LabelingSUPPL62AP2018-12-12STANDARD
EFFICACY; EfficacySUPPL63AP2019-06-28STANDARD

Submissions Property Types

SUPPL50Null0
SUPPL51Null0
SUPPL52Null0
SUPPL53Null0
SUPPL54Null0
SUPPL58Null15
SUPPL61Null7
SUPPL62Null15
SUPPL63Null6

TE Codes

001PrescriptionAA
004PrescriptionAA
005PrescriptionAA
006PrescriptionAA

CDER Filings

CASPER PHARMA LLC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 10721
            [companyName] => CASPER PHARMA LLC
            [docInserts] => ["",""]
            [products] => [{"drugName":"ANTIVERT","activeIngredients":"MECLIZINE HYDROCHLORIDE","strength":"50MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"ANTIVERT","activeIngredients":"MECLIZINE HYDROCHLORIDE","strength":"25MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"ANTIVERT","activeIngredients":"MECLIZINE HYDROCHLORIDE","strength":"25MG","dosageForm":"TABLET, CHEWABLE;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"},{"drugName":"ANTIVERT","activeIngredients":"MECLIZINE HYDROCHLORIDE","strength":"12.5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"Yes","rs":"No"}]
            [labels] => [{"actionDate":"06\/28\/2019","submission":"SUPPL-63","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2019\\\/010721s063lbl.pdf\"}]","notes":""},{"actionDate":"12\/12\/2018","submission":"SUPPL-62","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/010721Orig1s062_CartonLbl.pdf\"}]","notes":""},{"actionDate":"12\/12\/2018","submission":"SUPPL-62","supplementCategories":"Labeling-Container\/Carton Labels","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/017210s062lbl.pdf\"}]","notes":""},{"actionDate":"04\/13\/2018","submission":"SUPPL-61","supplementCategories":"Efficacy-Labeling Change With Clinical Data","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2018\\\/010721s061lbl.pdf\"}]","notes":""},{"actionDate":"10\/23\/2012","submission":"SUPPL-58","supplementCategories":"Labeling-Package Insert","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2012\\\/010721s058lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"ANTIVERT","submission":"MECLIZINE HYDROCHLORIDE","actionType":"50MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"ANTIVERT","submission":"MECLIZINE HYDROCHLORIDE","actionType":"25MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"ANTIVERT","submission":"MECLIZINE HYDROCHLORIDE","actionType":"25MG","submissionClassification":"TABLET, CHEWABLE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"},{"actionDate":"ANTIVERT","submission":"MECLIZINE HYDROCHLORIDE","actionType":"12.5MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">Yes"}]
            [supplements] => 
            [actionDate] => 2019-06-28
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.